This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Sources: Australasian College of Pharmacy. Management of reflux: a guideline for pharmacists. Queensland Health. Queensland Community Pharmacy Gastro-oesophageal Reflux and Gastro-oesophageal Reflux Disease – Clinical Practice Guideline. NSW Health. NSW Pharmacist Practice Standards for gastro-oesophageal reflux and gastro-oesophageal reflux disease.[/caption]
Dr Ming S Soh PhD, BPharm (Hons)[/caption]
Case scenario
Ping, 45, is a regular patient of the pharmacy and presents a repeat script for nortriptyline. He has had a partial response to this medicine, reporting improvements in chronic pain. When you inquire about any potential new medicines, he mentions he recently visited a new GP who prescribed a trial of a THC-dominant medicinal cannabis flower dried for vaporization, which he is yet to have dispensed. The new GP was not aware of his nortriptyline use.
Learning objectivesAfter completing this activity pharmacists should be able to:
Competency (2016) standards addressed: 1.1, 1.4, 1.5, 2.2, 3.1, 3.2, 3.3, 3.5 |
Already read the CPD i
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.
